4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-006311
Chief Medical Officer sold 40,000 shares at an average $58.95 ($2,358,117)
- Chief Medical Officer acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BALDO LANCE · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-27 | Exercise or conversion : show line 1 in the form | +40,000 | $7.80 | $312,000 | 40,000 | D |
| 2021-01-27 | Sale : show line 2 in the form | −17,499 | $58.22 | $1,018,792 | 22,501 | D |
| 2021-01-27 | Sale : show line 3 in the form | −14,233 | $59.24 | $843,163 | 8,268 | D |
| 2021-01-27 | Sale : show line 4 in the form | −8,268 | $60.01 | $496,163 | 0 | D |
| Open-market sales · 40,000 sh · avg $58.95 · $2,358,117 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-27 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −40,000 | 341,250 | D |
Loading xslF345X03/doc4.xml…